Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Momina Krepost ADXBUL:MKR 9 Days Payable is 336.14 as of Jun. 2026, which is 370% above its 10-year median of 71.59. GuruFocus rates XBUL:MKR with a GF Score™ of 9/100 and a GF Value™ of €1.83 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 793 Medical Devices & Instruments companies, Momina Krepost AD ranks better than 92.56% on this metric.
The historical rank and industry rank for Momina Krepost AD's Days Payable or its related term are showing as below:
XBUL:MKR'
s Days Payable Range Over the Past 10 Years
Min: 13.37 Med: 71.59 Max: 451.78
Current: 451.78
During the past 13 years, Momina Krepost AD's highest Days Payable was 451.78. The lowest was 13.37. And the median was 71.59.
XBUL:MKR's Days Payable is ranked better than 92.56% of 793
companies
in the Medical Devices & Instruments industry
Industry Median: 68.47
vs XBUL:MKR: 451.78
Momina Krepost AD's Days Payable
declined
from Jun. 2025 (390.35) to Jun. 2026 (336.14).
It may suggest that Momina Krepost ADaccelerated paying its suppliers.
The historical data trend for Momina Krepost AD's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XBUL:MKR vs ISRG, BDX, MDLN: Days Payable Comparison
For the Medical Instruments & Supplies subindustry, Momina Krepost AD's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Momina Krepost AD Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Momina Krepost AD's Days Payable distribution charts can be found below:
* The bar in red indicates where Momina Krepost AD's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Momina Krepost AD's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Momina Krepost AD (XBUL:MKR) has a Days Payable of 336.14 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Momina Krepost AD and its competitors. This is 370% above median its historical median of 71.59. Over the past decade, Momina Krepost AD's Days Payable has ranged from 13.37 to 451.78. According to the industry distribution chart, Momina Krepost AD ranks #59 out of 793 companies in the Medical Devices & Instruments industry, placing it in the top 7.4%.
Is Momina Krepost AD's Days Payable too high?
Momina Krepost AD's current Days Payable of 336.14 is 370% above median its 10-year median of 71.59. Over the past 10 years, this metric has ranged from a low of 13.37 to a high of 451.78. The Medical Devices & Instruments industry median Days Payable is 68.47. Momina Krepost AD's value of 336.14 is 390.9% above this industry median. Based on the distribution chart, Momina Krepost AD ranks #59 out of 793 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Momina Krepost AD has a GF Score™ of 9/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Momina Krepost AD's Days Payable compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Momina Krepost AD ranks #59 out of 793 companies for Days Payable. This places Momina Krepost AD in the top 7% of its industry — outperforming the majority of peers. The industry median Days Payable is 68.47. Momina Krepost AD's value of 336.14 is 390.9% above this benchmark. Historically, Momina Krepost AD's own Days Payable has ranged from 13.37 to 451.78 over the past decade. While the company's 10-year median is 71.59 vs. the industry median of 68.47, Momina Krepost AD has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.47, based on 793 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Momina Krepost AD's current Days Payable of 336.14 is 390.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Momina Krepost AD and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Momina Krepost AD's current Days Payable is 336.14, which is 370% above median its own 10-year median of 71.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Momina Krepost AD stock overvalued right now?
Based on GuruFocus' analysis, Momina Krepost AD (XBUL:MKR) is currently considered Possible Value Trap. The stock's GF Value™ is €1.83, compared to a current price of €0.50 — trading 72.7% below its estimated fair value. The current Days Payable is 336.14, which is 370% above median its 10-year median of 71.59 and 390.9% above the Medical Devices & Instruments industry median of 68.47. Momina Krepost AD's overall GF Score™ is 9/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Momina Krepost AD (XBUL:MKR), the current Days Payable is 336.14 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Momina Krepost AD (XBUL:MKR) Overvalued in 2026?
Based on GuruFocus' analysis, Momina Krepost AD stock appears to be undervalued.
The current stock price of €0.50 is trading 72.7% below its estimated GF Value™ of €1.83.
GuruFocus considers Momina Krepost AD to be Possible Value Trap.
Key valuation signals for XBUL:MKR:
Days Payable: 336.14 (370% above median its 10-year median of 71.59)
GF Value™: €1.83 vs. price of €0.50 (72.7% below fair value)
Industry Position: 390.9% above the Medical Devices & Instruments median (#59 of 793)
No single metric tells the full story. See the XBUL:MKR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Momina Krepost AD is engaged in the production and sales of medical products. The product portfolio includes syringes, injection needles, tubes, catheter, medical clothes, urine collecting bags, among others.
9GF Score
Get the complete analysis for XBUL:MKR
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XBUL:MKR has been successfully added to your 
